Squamous Cell Carcinoma Antigen 1 (SCCA1) Kits ELISA

May act as a protease inhibitor to modulate the host immune response against tumor cells.. De plus, nous expédions Squamous Cell Carcinoma Antigen 1 Anticorps (6) et Squamous Cell Carcinoma Antigen 1 Protéines (3) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
SCCA1 6317 P29508
SCCA1    
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top Squamous Cell Carcinoma Antigen 1 Kits ELISA sur anticorps-enligne.fr

Showing 10 out of 12 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Humain 34 pg/mL 78.125 pg/mL - 5000 pg/mL 96 Tests 15 to 17 Days
$870.62
Détails
Rat 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Lapin 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Cobaye 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Souris 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Singe 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Porc
  96 Tests 15 to 18 Days
$707.14
Détails
Chien 1.0 pg/mL 25-500 pg/mL   96 Tests 15 to 18 Days
$707.14
Détails
Mouton
  96 Tests 15 to 18 Days
$707.14
Détails
Boeuf (Vache)
  96 Tests 15 to 18 Days
$707.14
Détails

Plus Kits ELISA pour Squamous Cell Carcinoma Antigen 1 partenaires d'interaction

Human Squamous Cell Carcinoma Antigen 1 (SCCA1) interaction partners

  1. further showed a disease state mutant SPB3-Gly351Ala performed better anti-protease activity against FP2. This study, for the first time, has shown a serpin family inhibitor from human could efficiently inhibit activity of FP2.

  2. this study shows that SERPINB4 contributes to survival of allergenic TH2 cells

  3. SCCA2 is a reliable biomarker.

  4. Fifty-two of 96 cases (54%) showed evaluated serum SCC antigen levels above the upper limit. The serum SCCA2 level was significantly higher in the head and neck SCC patients than in control group, whereas there were no significant differences in the serum SCCA1 level between head and neck SCC patients and control group.

  5. Results provide evidence that SCCA1 overexpression is associated with poor prognosis in esophageal cancer patients. which is due to reduced tumor chemosensitivity as well as intratumoral immunity impairment, possibly mediated by the induction of the PD-L1 immune checkpoint regulator.

  6. Concurrent elevation of preoperative SCC-Ag, CYFRA 21-1 and CRP serum levels can be correlated with worse survival rates in oral cavity squamous cell carcinoma.

  7. While novel diagnostic tumour markers are urgently needed, the examined potential tumour markers, with the exception of PIVKAII seem to be inadequate for diagnosing HCC in ALC

  8. Results provide the first evidence that failure of serum SCCA to fall into the normal range by the fourth week of definitive radiotherapy is associated with significantly increased risk of recurrence and death.

  9. The combination of SCCA-IgM with common clinical data shows promising diagnostic performance for the detection of Non-alcoholic steato-hepatitis in hepatitis C virus patients

  10. Both periostin and SCCA may play a role in the pathogenesis of acute bronchitis due to respiratory syncytial virus

  11. iron overload and was previously found capable of up-regulating SerpinB3 at the transcriptional level.

  12. the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.

  13. Serum SCC-Ag, hs-CRP, and CA-125 were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.

  14. A close connection between SerpinB3 and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.

  15. Findings point to potential interest of squamous cell carcinoma antigen SERPINB3/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.

  16. Serum SCCA2 levels reflected disease severity and clinical type of atopic dermatitis. Serum SCCA2 may thus be a relevant biomarker for atopic dermatitis.

  17. role of SERPINB3/B4 mutations in immunotherapy response

Squamous Cell Carcinoma Antigen 1 (SCCA1) profil antigène

Antigen Summary

May act as a protease inhibitor to modulate the host immune response against tumor cells.

Gene names and symbols associated with SCCA1

  • serpin family B member 3 (SERPINB3) anticorps
  • serpin family B member 4 (SERPINB4) anticorps
  • HsT1196 anticorps
  • LEUPIN anticorps
  • PI11 anticorps
  • SCC anticorps
  • SCCA-1 anticorps
  • SCCA-2 anticorps
  • SCCA-PD anticorps
  • SCCA1 anticorps
  • SCCA2 anticorps
  • T4-A anticorps

Protein level used designations for SCCA1

protein T4-A , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3 , serpin B3 , squamous cell carcinoma antigen 1 , PI-11 , SCCA2/SCCA1 fusion protein , peptidase inhibitor 11 , protease inhibitor (leucine-serpin) , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 4 , serpin B4 , squamous cell carcinoma antigen 2

GENE ID SPECIES
6317 Homo sapiens
6318 Homo sapiens
Fournisseurs de qualité sélectionnés pour Squamous Cell Carcinoma Antigen 1 (SCCA1) Kits ELISA
Avez-vous cherché autre chose?